Alzheimer's disease biomarker development: a call to funding bodies.
Departments of Psychiatry and General Internal Medicine Rehabilitation and Geriatrics, University Hospitals and University of Geneva, Geneva, Switzerland; Alzheimer's Imaging and Epidemiology Unit, IRCCS Fatebenefratelli, Brescia, Italy. Electronic address: giovanni.frisoni@unige.ch.
Giovanni B
GB
Frisoni
Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Clifford R
CR
Jack
Center for Alzheimer Research, Division of Neurogeriatrics, Department of NVS, Karolinska Institutet, Huddinge, Sweden.
Bengt
B
Winblad
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D001284:Atrophy; D015415:Biomarkers / Q000134:cerebrospinal fluid; D006624:Hippocampus / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D010446:Peptide Fragments / Q000134:cerebrospinal fluid; D049268:Positron-Emission Tomography; D016875:tau Proteins / Q000134:cerebrospinal fluid
D016229:Amyloid beta-Peptides; D015415:Biomarkers; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D016875:tau Proteins